Journal Club VL

NCCN 2023 Updates and Mini-Section on Quality-of-Life and Shared-Decision Making, Journal Club - Christopher J.D. Wallis & Zachary Klaassen

Details
Chris Wallace and Zach Klaassen discuss updates in the 2023 NCCN Clinical Practice Guidelines in Oncology for prostate cancer. They focus on a new section of the guidelines that emphasize the importance of shared decision-making and maintaining quality of life during prostate cancer treatment. As part of the guidelines, the panel recommends baseline measures of disease-specific functions, includin...

Stockholm3 Tests to Inform Risk Stratification before MRI and Targeted Biopsies in the Prostate Cancer Screening Setting, Journal Club - Zachary Klaassen

Details
In this UroToday Journal Club, Zachary Klaassen discusses the publication entitled Prostate Cancer Screening Using Combination of Risk Prediction, MRI, and Targeted Prostate Biopsies, the STHLM3-MRI trial. The study performed a prospective, randomized, population-based trial among men aged 50 to 74 to evaluate various prostate cancer screening strategies. The study showed that replacing PSA with S...

Genetic Scores as an Objective Measure of Prostate Cancer Risk To Inform Screening Decisions, a Retrospective Analysis of the Million Veteran Program, Journal Club - Zachary Klaassen

Details
In this UroToday Journal Club discussion, Zach Klaassen discusses the publication "Polygenic Risk of Any, Metastatic, and Fatal Prostate Cancer in the Million Veteran Program." The publication explores the potential use of genetic risk scores in identifying individuals most at risk of developing advanced prostate cancer, particularly those who may benefit most from PSA testing and screening. The p...

Rectal Spacing With Hyaluronic Acid for Hypofractionated Radiation Therapy for Prostate Cancer, Barrigel®, Journal Club - Zachary Klaassen

Details
In this UroToday Journal Club discussion, Zach Klaassen discusses the publication "Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial." The study evaluates the effectiveness of a hyaluronic acid rectal spacer in reducing the risk of acute gastrointestinal toxicity in patients undergoing hypofractionated radiation therapy for prostate cancer. The stu...

MRI-Guided vs CT-Guided Stereotactic Body Radiotherapy for Prostate Cancer, The MIRAGE Randomized Clinical Trial Journal Club - Zachary Klaassen

Details
In this UroToday Journal Club discussion, Zach Klaassen discusses the publication "Magnetic Resonance Imaging-Guided Versus CT-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial." This study compared CT-guided and MRI-guided SBRT for localized prostate cancer. Results showed that the aggressive margin reduction afforded by MRI guidance allowed a substan...

Active Surveillance as a Safe Strategy for Disease Management Among Men With Prostate Cancer: Findings From a Swedish Cohort Study, Journal Club - Zachary Klaassen

Details
In this UroToday Journal Club discussion, Zach Klaassen discusses the publication "Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden." The study aims to investigate the long-term outcomes following active surveillance for prostate cancer using a state transition model. Data from the Swedish prostate cancer database included men aged 40 to 75 years diagnosed...

Analyzing the ARASENS Trial: Darolutamide Boosts Survival in Prostate Cancer Subgroups Journal Club - Zachary Klaassen

Details
In this UroToday Journal Club discussion, Zach Klaassen analyzes the Journal of Clinical Oncology publication, "Darolutamide Plus ADT and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial." The ARASENS trial, a multicenter, randomized, double-blind, placebo-controlled Phase III study across 23 countries, assesses the combi...

The Association of the Pandemic With Prostate Biopsy and Prostate Cancer Diagnosis Rates Among Black vs White Patients in the Veterans Affairs Health Care System Journal Club - Zachary Klaassen

Details
In this UroToday Journal Club, Zachary Klaassen discusses the publication “Association of the COVID-19 Pandemic With Rates of Prostate Cancer Biopsy and Diagnoses in Black Versus White US Veterans.”. The study used a retrospective analysis of all prostate biopsies performed in the VA system between January 2018 and March 2021, excluding men with a pre-existing diagnosis of prostate cancer. The stu...

mpMRI What Urologists Need to Know: Targeted Biopsy - Zachary Klaassen

Details
In this UroToday Journal Club, Zach Klaassen discusses part three of the publication "Multiparametric MRI - What Urologists Need to Know" focusing on Targeted Biopsy. Drs. Wallis and Klaassen review the advantages and disadvantages of three different approaches of MRI-targeted biopsy for prostate cancer detection: cognitive fusion, MRI-TRUS fusion, and direct in-bore MRI-guided biopsy. Fusion MR-g...

Mediators of Racial Disparities in Prostate mpMRI Journal Club - Zachary Klaassen

Details
In this UroToday Journal Club, Zachary Klaassen discusses “Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.” This study examines racial disparities in the use of prostate MRI among patients with prostate cancer in the US. The study used a population-based cohort and multiple mediation analysis to identify factors underlining dispa...